Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway
Back to article page
Original Article|Updated:2021-08-27
|
Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway
Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway
Chinese Journal of Integrative Medicine2019年25卷第2期 页码:116-121
Affiliations:
1.College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou (350122), China
2.Fujian Key Laboratory of Integrative Medicine on Geriatric, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou (350122), China
Author bio:
Correspondence to: Prof. PENG Jun, Tel: 86-591-22861303, E-mail: pjunlab@hotmail.com
Funds:
the National Natural Science Foundation of China(81673721);Natural Science Foundation of Fujian Province(2017I0007)
Si-zhou HUANG, Wang-yu LIU, Yue HUANG, 等. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway[J]. Chinese Journal of Integrative Medicine, 2019,25(2):116-121.
Si-zhou HUANG, Wang-yu LIU, Yue HUANG, et al. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway[J]. Chinese Journal of Integrative Medicine, 2019,25(2):116-121.
Si-zhou HUANG, Wang-yu LIU, Yue HUANG, 等. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway[J]. Chinese Journal of Integrative Medicine, 2019,25(2):116-121. DOI: 10.1007/s11655-018-3002-6.
Si-zhou HUANG, Wang-yu LIU, Yue HUANG, et al. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway[J]. Chinese Journal of Integrative Medicine, 2019,25(2):116-121. DOI: 10.1007/s11655-018-3002-6.
Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway
摘要
Abstract
Objective:
2
To investigate the effects of ethanol extract of
Patrinia scabiosaefolia
(EEPS) on chemo-resistance of colorectal cancer cells (CRC) and explore the possible molecular mechanisms.
Methods:
2
5-fluorouracil (5-FU)-resistant human colorectal carcinoma cell line (HCT-8/5-FU) and its parental cells HCT-8 were treated with EEPS (0
0.25
0.50
1 or 2 mg/mL)
or 5-FU (0
100
200
400
800 or 1600 μmol/L). The 3-(4
5-dimethylthiazol-2-yl)-2
5-diphenyltetrazolium bromide (MTT) assay was performed to evaluate the cell viability. Cell density was observed by phase-contrast microscope
cell counting and colony formation assay were used to determine the cell proliferation of HCT-8/5-FU cells treated with 0
0.5
1 or 2 mg/mL EEPS. Cell apoptosis was determined by Hoechst staining. Western-blot was performed to detect the phosphorylation of AKT as well as the protein expression level of B-cell CLL/lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax).
Results:
2
Compared with HCT-8 cells
MTT assay results indicated that HCT-8/5-FU cells were resistant to 5-FU treatment (
P
<
0.05)
and sensitive to EEPS treatment (
P
>
0.05). Moreover
compared with untreated HCT-8/5-FU cells
1 and 2 mg/mL of EEPS treatment significantly reduced cell density
cell number
inhibited cell survival (
P
<
0.05)
and induced apoptosis in HCT-8/5-FU cells. Furthermore
1 and 2 mg/mL of EEPS significantly decreased the phosphorylation level of p-AKT and Bcl-2 protein expression
and increased the expression of Bax protein (
P
<
0.05).
Conclusion:
2
EEPS is a promising therapeutic agent that may overcome chemo-resistance in cancer cells
likely through suppression of the AKT pathway and promotion of cancer cell apoptosis.
关键词
Keywords
AKT pathwaycolorectal cancer5-fluorouracil resistancePatrinia scabiosaefoliaChinese medicine
Effectiveness and Safety Evaluation of Chinese Medicine in Treatment of Metastatic Colorectal Cancer after Chemotherapy Failure: Protocol of a Prospective Multicenter Cohort Study
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice
相关作者
暂无数据
相关机构
Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences
Chinese Mdeicine Center for AIDS Prevention and Treatment, China Academy of Chinese Medical Sciences
Department of Oncology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine
Institute of Clinical Pharmacology, Xiyuan Hospital, China Academy of Chinese Medicine Sciences
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine